OXENHORN ELI
SC 13D, 1997-06-27
Previous: US XPRESS ENTERPRISES INC, 10-K, 1997-06-27
Next: INVESCO SPECIALTY FUNDS INC, 485BPOS, 1997-06-27



                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                               S C H E D U L E  13D

                    Under the Securities Exchange Act of 1934
                                (Amendment No. )*

                                ENTERACTIVE, INC.
- --------------------------------------------------------------------------------
                                (Name of Issuer)


                          COMMON STOCK, $0.01 PAR VALUE
- --------------------------------------------------------------------------------
                         (Title of Class of Securities)

                                    293636106
- --------------------------------------------------------------------------------
                                 (CUSIP Number)
                                    Copy to:
                                         Stephen A. Cohen, Esq.
Eli Oxenhorn                             Morrison Cohen Singer & Weinstein, LLP
56 The Intervale                         750 Lexington Avenue
Roslyn, New York 11576                   New York, New York 10022
Telephone (516) 625-7005                 Telephone (212) 735-8600

- --------------------------------------------------------------------------------
                 (Name, Address and Telephone Number of Persons
                Authorized to Receive Notices and Communications)

                                  JUNE 17, 1997
- --------------------------------------------------------------------------------
              (Date of Event which Requires Filing this Statement)

If the filing person has previously  filed a statement on Schedule 13G to report
the  acquisition  which is the subject of this  Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following space .

NOTE: Six copies of this statement, including all exhibits, should be filed with
the  Commission.  See Rule  13d-1(a) for other  parties to whom copies are to be
sent.

*The  remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for  any  subsequent   amendment   containing   information  which  would  alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).

                        (Continued on following page(s))

                                   - 1 of 10 -
<PAGE>

CUSIP
No.   293636106         13D
================================================================================
 1          Name of Reporting Person
            S.S. or I.R.S. Identification No. of Above Person
                                  Eli Oxenhorn

- --------------------------------------------------------------------------------
 2          Check the Appropriate Box if a Member of a Group*             (a) //
                                                                          (b) //
- --------------------------------------------------------------------------------
 3          SEC Use Only
- --------------------------------------------------------------------------------
 4          Source of Funds*          PF
- --------------------------------------------------------------------------------
 5          Check Box if Disclosure of Legal Proceedings is Required
            Pursuant to Item 2(d) or 2(e)
- --------------------------------------------------------------------------------
 6          Citizenship or Place of Organization                   United States
- --------------------------------------------------------------------------------
       Number of Shares Beneficially Owned by Each Reporting Person with.
           ---------------------------------------------------------------------
                7      Sole Voting Power
                            313,000 shares                                  4.0%
           ---------------------------------------------------------------------
                8      Shared Voting Power
                            400,000 shares                                  4.9%
           ---------------------------------------------------------------------
                9      Sole Dispositive Power
                            313,000 shares                                  4.0%
           ---------------------------------------------------------------------
               10      Shared Dispositive Power
                            400,000 shares                                  4.9%
- --------------------------------------------------------------------------------
11        Aggregate Amount Beneficially Owned By Each Reporting Person
                                 713,000 shares
- --------------------------------------------------------------------------------
12        Check Box if the Aggregate Amount in Row (11) excludes Certain Shares*

- --------------------------------------------------------------------------------
13        Percent of Class Represented by Amount in Row (11)
                                                                            8.6%
- --------------------------------------------------------------------------------
14        Type of Reporting Person*
                              IN

================================================================================
                      *SEE INSTRUCTIONS BEFORE FILLING OUT!

                                    -2 of 10-

<PAGE>



     This  statement,  dated June 17, 1997,  relates to the  reporting  person's
ownership of certain securities of Enteractive, Inc. (the "Issuer").

ITEM 1.     SECURITY AND ISSUER

         (a) Common Stock, 0.01 par value per share (CUSIP No. 293636106).

         (b)  Warrants  ("1994  Warrants"),  entitling  the  holder  thereof  to
 purchase  25,500 shares of Common Stock at $2.35 per share,  exercisable at any
 time prior to January 1999.

         (c)  Option  ("Option")  to  purchase  50,000  shares of Common  Stock,
 expiring  January 3, 2004,  entitling the holder thereof to purchase the Common
 Stock at $2.35 per share, exercisable as of January 3, 1995.

         (d)  Non-Qualified  Stock Option  ("Non-Qualified  Option") to purchase
 125,000  shares of Common Stock,  expiring on November 10, 2004,  entitling the
 holder  thereof to purchase  the Common  Stock at $3.75 per share,  exercisable
 commencing on November 10, 1995.

         (e) Option  ("Revwood  Option")  to purchase  400,000  shares of Common
 Stock  expiring on November 4, 1999,  entitling the holder  thereof to purchase
 the shares of Common Stock at $2.375 per share, exercisable on August 15, 1997,
 issued to Revwood General Partners.

         (f)         Enteractive, Inc.
                     Suite 2100
                     110 West 40th Street
                     New York, New York 10018


ITEM 2.     IDENTITY AND BACKGROUND

 1.     (a)     Eli Oxenhorn

        (b)     Address:
                    56 The Intervale
                    Roslyn, New York 11576

        (c) Principal Occupation: Consultant

        (d) Within the last five (5) years,  Eli Oxenhorn has not been convicted
in  any  criminal   proceeding   (excluding   traffic   violations  and  similar
misdemeanors, if any).

        (e) Within the last five (5) years, Eli Oxenhorn has not been a party to
any  civil  proceeding  of  a  judicial  or  administrative  body  of  competent
jurisdiction  which  resulted in a judgment,  decree,  or final order  enjoining
future violations of, or prohibiting or mandating activities subject to, federal
or state securities laws or a finding of a violation with respect to such laws.

                                    -3 of 10-
<PAGE>

     (f) Citizenship: United States.


ITEM 3.     SOURCE AND AMOUNTS OF FUNDS OR OTHER CONSIDERATION

     The reporting person obtained funds for the purchase of the securities from
his personal funds.

     On August 31, 1994,  Revwood Merchant  Partners  ("Revwood"),  of which Eli
Oxenhorn is a general partner,  acquired  restricted shares of Common Stock in a
private  transaction.  On December 2, 1994 Revwood distributed 37,500 restricted
shares of Common Stock to each of its general partners.

     The  Board  of  Directors   of  the  Issuer   approved  the  grant  of  the
Non-Qualified  Option  to Eli  Oxenhorn,  as of  November  10,  1994,  under the
Issuer's 1994 Stock Option Plan for Consultants.

     On June 16, 1995,  Revwood made a capital  distribution  to each of its two
general partners in the form of the Option.  The capital  distribution was of an
option to the Issuer previously granted to Revwood as of January 3, 1994.

     Effective  November 4, 1996, the Board of Directors of the Issuer granted a
three-year  option to purchase  400,000  shares of the Issuer's  Common Stock to
Revwood  at a price of $2.375 per share.  The  Option is not  exercisable  until
August 15, 1997.

     The amount of funds used in making  the  purchases  of the shares of Common
Stock are set forth below:

         NAME                                 AMOUNT OF CONSIDERATION
         ----                                --------------------------

         Eli Oxenhorn                                  $315,400


ITEM 4.     PURPOSE OF TRANSACTION.

     The reporting person acquired his securities for purposes of investment.
The reporting person does not have any plans or proposals which relate to or
would result in any of the actions set forth in subparagraphs (a) through (j) of
Item 4 of Schedule 13D .


ITEM 5.     INTERESTS IN SECURITIES OF THE ISSUER.

     (a) The following list sets forth the aggregate number and percentage
(based on 7,679,441 shares of Common Stock outstanding as reported in the
Issuer's Prospectus dated April 11, 1997) of outstanding shares of Common Stock
owned beneficially by the reporting person named in Item 2, as of June 17, 1997:


                                   - 4 of 10 -
<PAGE>



                               Shares of                 Percentage of Shares
                             Common Stock                   of Common Stock
    Name                  Beneficially Owned              Beneficially Owned
    ----                  ------------------              ------------------
Eli Oxenhorn                  713,000(1)                          8.6%

     (b) Eli  Oxenhorn  has sole power to vote and dispose of 313,000  shares of
Common  Stock  (including  200,500  shares  issuable  upon the  exercise  of the
Non-Qualified   Option,   the  Option  and  the  1994  Warrants),   representing
approximately 4.0% of the outstanding Common Stock. By virtue of being a general
partner of Revwood,  Eli Oxenhorn may be deemed to have shared power to vote and
to dispose of 400,000 shares of Common Stock (including  400,000 shares issuable
upon the exercise of the Revwood Option), representing approximately 4.9% of the
outstanding Common Stock.

     (c) There were no  transactions  in any of the  securities of the Issuer by
the person  identified in Item 2 of this  Schedule 13D effective  from April 17,
1997 through June 17, 1997, inclusive.

     (d) No other  person  has the right to  receive  or the power to direct the
receipt of dividends from, or the proceeds from the sale of such securities.

     (e) Not applicable.


ITEM 7. MATERIAL TO BE FILED AS EXHIBITS

     EXHIBIT A - Option  Agreement,  dated  November 12, 1996 between the Issuer
and Revwood General Partners.

- -----------------
     1  The reporting person disclaims beneficial ownership of these securities,
except to the extent of his equity interest therin.

                                    -5 of 10-


<PAGE>

                                    SIGNATURE

     After reasonable  inquiry and to the best of his knowledge and belief,  the
undersigned  hereby certifies that the information set forth in this Schedule is
true, complete, and correct.

Date: June 27, 1997

                                                            /s/  ELI OXENHORN
                                                            Eli Oxenhorn
 

ATTENTION:  INTENTIONAL  MISSTATEMENTS  OR OMISSIONS OF FACT CONSTITUTE  FEDERAL
CRIMINAL VIOLATIONS (SEE 18 U.S.C. 1001).


                                    -6 of 10-

<PAGE>


                                                                       Exhibit A

                                 ENTERACTIVE, INC.
                                110 West 40th Street
                              New York, New York 10018


Revwood General Partners
c/o Mr. Eli Oxenhorn
56 The Intervale
Roslyn Estates
Roslyn, NY 11576

Gentlemen:

     In  connection  with  certain  services  you are  performing  on  behalf of
Enteractive,  Inc. (the  "Company") we are pleased to inform you that  effective
November 4, 1996 the Board of Directors of the Company  granted you an option to
purchase  400,000  shares (the  "Shares")  of Common  Stock,  par value $.01 per
share, of the Company, at a price of $2.375 per Share.

     No part of the option is currently exercisable. The option may be exercised
at any time on or after  August  15,  1997.  You must  purchase  a minimum of 50
Shares or more (but not  fractional  shares)  each time you  choose to  purchase
Shares,  except to purchase the  remaining  Shares  available to you. The option
will expire, to the extent it is not previously exercised, on November 4, 1999.

     In  the  case  of  any   reclassification   of  the  Common  Stock  or  any
reorganization,  consolidation  or merger of the  Company  with or into  another
corporation  (other than a merger or  reorganization  with  respect to which the
Company  is  the  continuing  corporation  and  which  does  to  result  in  any
reclassification  of the Common  Stock),  the Board of  Directors  shall make an
appropriate  and equitable  adjustment in the number and kind of Shares reserved
for issuance under the option and in the number and kind of Shares  reserved for
issuance  under the option and in the number and option price of shares  subject
to the  outstanding  option  granted,  to the end that  after  such  event  your
proportionate  interest shall be maintained as immediately before the occurrence
of such event.

     The  granting  and  exercise  of the  option  granted  hereunder,  and  the
obligation of the Company to sell and deliver Shares under such option, shall be
subject to all applicable laws, rules and regulations,  and to such approvals by
any governmental agencies or national securities as may be required.


     All  certificates  for Shares  delivered  pursuant  to the  option  granted
hereunder shall be subject to such stock transfer orders and other  restrictions
as the Board of Directors may deem advisable under the rules,  regulations,  and
other requirements of the Securities and Exchange Commission, any stock exchange

                                    -7 of 10-

<PAGE>

upon which the  Shares  are then  listed,  and any  applicable  Federal or state
securities  law, and the Board of Directors  may cause a legend or legends to be
placed  on  any  such  certificates  to  make  appropriate   reference  to  such
restrictions.

     Unless at the time of the exercise of this option a registration  statement
under the  Securities  act of 1933,  as amended (the "Act"),  is in effect as to
such Shares,  any Shares purchased by you upon the exercise of this option shall
be acquired for investment and not for sale or distribution,  and if the Company
so requests,  upon any exercise of this  option,  in whole or in part,  you will
execute and deliver to the Company a  certificate  to such  effect.  The Company
shall not be  obligated  to issue any Shares  pursuant to this option if, in the
opinion of counsel to the Company, the Shares to be so issued are required to be
registered or otherwise  qualified  under the Act or under any other  applicable
statute,  regulation or ordinance  affecting the sale of securities,  unless and
until such Shares have been so registered or otherwise qualified.

     You understand and acknowledge that, under existing law, unless at the time
of the  exercise of this  option a  registration  statement  under the Act is in
effect as to such Shares (i) any Shares  purchased by you upon  exercise of this
option  may  be  required  to  be  held  indefinitely  unless  such  Shares  are
subsequently  registered under the Act or an exemption from such registration is
available;  (ii)  any  sales  of such  Shares  made in  reliance  upon  rule 144
promulgated  under  the Act may be made  only in  accordance  with the terms and
conditions of that Rule (which, under certain circumstances, restrict the number
of shares which may be sold and the manner in which  shares may be sold);  (iii)
in the case of securities to which Rule 144 is not  applicable,  compliance with
Regulations A promulgated under the act or some other disclosure  exemption will
be required;  (iv)  certificates  for Shares to be issued to you hereunder shall
bear a legend to the effect that the Shares have not been  registered  under the
Act and that the Shares may not be sold,  hypothecated or otherwise  transferred
in the absence of an  effective  registration  statement  under the Act relating
thereto  or an  opinion  of  counsel  satisfactory  to  the  Company  that  such
registration  is not required;  (v) the Company will place an appropriate  "stop
transfer"  order with its transfer  agent with respect to such Shares;  and (vi)
the Company has  undertaken  no  obligation to register the Shares or to include
the Shares in any registration  statement which may be filed by it subsequent to
the issuance of the shares to you. In addition,  you understand and  acknowledge
that the Company has no  obligation to you to furnish  information  necessary to
enable you to make sales under Rule 144.

     No member of the Board of  Directors,  or any  officer or  employee  of the
Company  acting on behalf  of the  Board,  shall be  personally  liable  for any
action, determination,  or personally liable for any action,  determination,  or
interpretation  taken or make in good faith with  respect to the option  granted
hereunder,  and all members of the Board and each and any officer or employee of
the Company  acting on their behalf  shall,  to the extent  permitted by law, be
fully  indemnified  and  protected by the Company in respect of any such action,
determination or interpretation.

     This option (or  installment  thereof) is to be exercised by  delivering to
the Company a written notice of exercise in the form attached  hereto as Exhibit
A, specifying the number of Shares to be purchased, together with payment of the
purchase  price of the Shares to be purchased.  The purchase price is to be paid
in cash or, at the discretion of the Board of Directors, by delivering shares of
the  Company's  stock already owned by you and having a fair market value on the
date of exercise equal to the exercise price of the option,  or a combination of
such shares and cash. 

                                   -8 of 10-

<PAGE>

     Would you kindly evidence your acceptance of this option and your agreement
to comply with the  provisions  hereof by executing  this letter under the words
"Agreed To and Accepted."

                                     Very truly yours,
                                     ENTERACTIVE, INC.


                                     By: /s/ ANDRES GYENES
                                             Andrew Gyenes, Chairman of the
                                             Board and Chief Executive
                                                Officer


AGREED TO AND ACCEPTED:

REVWOOD GENERAL PARTNERS

By:     /s/ ELI OXENHORN
       -----------------
       Eli Oxenhorn

                                    -9 of 10-

<PAGE>

Enteractive, Inc.
110 West 40th Street
New York, New York   10018

Gentlemen:

     Notice is hereby  given of my  election  to  purchase  _________  shares of
Common Stock, $.01 par value (the "Shares"), of Enteractive,  Inc. at a price of
$2.375  per Share,  pursuant  to the  provisions  of the  option  granted  to me
effective  on  November  4, 1996.  Enclosed in payment for the Shares is:

               / / my check in the amount of $_________. * 
               / /                            _________ Shares having a 
                                              total value

                     $_______, such value being based on the
                     closing price(s) of the Shares on the date
                     hereof.

     The following  information  is supplied for use in issuing and  registering
the Shares purchased hereby:

            Number of Certificates
                 and Denominations                          --------------------

            Name                                            --------------------

            Address                                         --------------------

                                                            --------------------

                                                            --------------------

            Social Security Number                          --------------------

Dated:  ____________, 19__


                                                       Very truly yours,

                                                      ----------------------

*Subject to the approval of the
  Board of Directors


                                   -10 of 10-


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission